Neurocutaneous melanocytosis with manifestation in adulthood
https://doi.org/10.30629/2658-7947-2022-27-5-59-68
Abstract
A 20-year-old patient was presented with subacute onset of headache, nausea and vomiting. Testing of nasal/oropharyngeal swabs indicated the presence of SARS-CoV-2 RNA, and later the antibodies to this virus were found. The treatment in the hospital for Coronavirus 19 Disease (COVID-19) provided only temporary relief, and the patient then was referred to the Regional Stroke Center (RSC) to exclude a subarachnoid hemorrhage. RSC neurologists drew attention to multiple skin nevi in the patient. Brain MRI demonstrated abnormal T1 hyperintensity in the brain leptomeninges, with leptomeningeal contrast enhancement as well as hyperintensity in amygdala regions on T1 weighted images, bilaterally. The anomaly of the Dandy-Walker malformation complex was also revealed. Cerebrospinal fluid (CSF) analysis showed elevated protein (0.52 g/L), low lymphocytosis (lymphocytes, 6 in mm3), and decreased glucose (1.8 mmol/L). Neurocutaneous melanocytosis (NCM) was diagnosed, which neurological manifestation was probably triggered by COVID-19. The patient’s vision gradually progressively worsened. In 2.5 months after the clinical manifestation of NCM, fundoscopy revealed optic discs atrophy (despite the absence of previous edema), and repeated CSF analysis showed atypical cells with characteristics corresponding to melanoma. Malignant transformation of cerebral melanocytosis was suspected, and the patient was referred to an oncological dispensary for further therapy. In the presented literature review, special attention is paid to the issues of neuroimaging, cytological and immunocytochemical diagnostics of NCM.
About the Authors
V. N. GrigoryevaRussian Federation
Nizhny Novgorod
V. N. Nesterova
Russian Federation
Nizhny Novgorod
G. V. Tikhomirov
Russian Federation
Nizhny Novgorod
O. S. Klimova
Russian Federation
Nizhny Novgorod
I. V. Chudakova
Russian Federation
Nizhny Novgorod
References
1. Smith A.B., Rushing E.J., Smirniotopoulos J.G. Pigmented lesions of the central nervous system: radiologic-pathologic correlation. Radiographics. 2009;29(5):1503–1524. https://doi.org/10.1148/rg.295095109
2. Kolin D.L., Geddie W.R., Ko H.M. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis. Cytopathology. 2017;28(3):235–238. https://doi.org/10.1111/cyt.12366
3. Ruggieri M., Polizzi A., Catanzaro S., Bianco M.L., Praticò A.D., Di Rocco C. Neurocutaneous melanocytosis (melanosis). Childs Nerv Syst. 2020;36(10):2571–2596. https://doi.org/10.1007/s00381-020-04770-9
4. El Mabood S.A., Wahba Y., Yahia S., Sarhan M.M., Mansour A.K., Provenzano A., Elmahdi H.S., Darwish A. Neurocutaneous melanosis is not always a benign disease. Indian J Dermatol Venereol Leprol. 2020;86(3):335. https://doi.org/10.4103/ijdvl.IJDVL_456_18
5. Kadonaga J., Frieden I. Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol. 1991;24:747–755. https://doi.org/10.1016/0190-9622(91)70115-I
6. Martins da Silva V.P., Marghoob A., Pigem R., Carrera C., Aguilera P., Puig-Butillé J.A. et al. Patterns of distribution of giant congenital melanocytic nevi (GCMN): the 6B rule. J Am Acad Dermatol. 2017;76:689–694. https://doi.org/10.1016/j.jaad.2016.05.042
7. Pellino G., Gencarelli J., Bertelli S., Russo A., Fiumana E., Faggioli R. Epilepsy in isolated parenchymal neurocutaneous melanosis: A systematic review. Epilepsy Behav. 2020;107:107061.https://doi.org/10.1016/j.yebeh.2020.107061
8. Bhatia R., Kataria V., Vibha D., Kakkar A., Prasad K., Mathur S. et al. Mystery Case: Neurocutaneous melanosis with diffuse leptomeningeal malignant melanoma in an adult. Neurology. 2016;86(8):e75–9. https://doi.org/10.1212/WNL.0000000000002396
9. Sharouf F., Zaben M., Lammie A., Leach P., Bhatti. Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update. Childs Nerv Syst. 2018;34(8):1471–1477. https://doi.org/10.1007/s00381-018-3851-5
10. Burstein F., Seier H., Hudgins P.A., Zapiach L. Neurocutaneous melanosis. Journal of Craniofacial Surgery. 2005;16(5):874–876. https://doi.org/10.1097/01.scs.0000181050.06696.4d
11. Мацко Д.Е., Мацко М.В., Имянитов Е.Н. Нейроонкология. Практическая онкология. 2017;18(1):103–114. [Macko D.E., Macko M.V., Imyanitov E.N. Neurooncology. Practical oncology. 2017;18(1):103–114. (In Russ.)].
12. Jakchairoongruang K., Khakoo Y., Beckwith M., Barkovich A.J. New insights into neurocutaneous melanosis. Pediatr Radiol. 2018;48(12):1786–1796. https://doi.org/10.1007/s00247-018-4205-x
13. Moreira B.L., Grunewald T., Côrtes A.A., Marussi V.H., do Amaral L.L. Neurocutaneous melanosis. Radiol Bras. 2016;49(6):412–413. https://doi.org/10.1590/0100-3984.2015.0128
14. Qian M., Ren H., Qu T., Lu Z., Zou Y., He J. et al. Spectrum of clinical, neuroimaging, and cerebrospinal fluid features of adult neurocutaneous melanocytosis. Eur Neurol. 2018;80(1–2):1–6. https://doi.org/10.1159/000488687
15. Mitre V., Heym K., Clark G.D., Venkatramani R. Neurocutaneous melanocytosis and leptomeningeal melanoma. J Pediatr Hematol Oncol. 2021;43(2):e195–e197. https://doi.org/10.1097/MPH.0000000000001680
16. Das K., Nair A., Jaiswal S., Sahu R., Srivastava A., Kumar R., Mehrotra A. Supratentorial intermediate grade meningeal melanocytoma with intratumoral bleed in the background of neurocutaneous melanosis: Report of an unusual case and review of literature. Asian J Neurosurg. 2017;12(1):98–102. https://doi.org/10.4103/1793-5482.145113
17. Girolami I., Cima L., Ghimenton C., Zannoni M., Mombello A., Riva G. et al. NRASQ61K mutated diffuse leptomeningeal melanomatosis in an adult patient with a brief review of the socalled “forme fruste” of neurocutaneous melanosis. Brain Tumor Pathol. 2018;35(4):217–223. https://doi.org/10.1007/s10014-018-0328-x
18. Chen L., Zhai L., Al-Kzayer L.F.Y., Sarsam S.N., Liu T., Alzakar R.H., Nakazawa Y. Neurocutaneous melanosis in association with large congenital melanocytic nevi in children: A report of 2 cases with clinical, radiological, and pathogenetic evaluation. Front Neurol. 2019;10:79. https://doi.org/10.3389/fneur.2019.00079
19. Fernández-Medarde A., De Las Rivas J., Santos E. 40 Years of RAS-a historic overview. Genes (Basel). 2021;12(5):681. https://doi.org/10.3390/genes12050681
20. Kinsler V.A., Thomas A.C., Ishida M., Bulstrode N.W., Loughlin S., Hing S. et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol. 2013;133(9):2229–2236. https://doi.org/10.1038/jid.2013.70
21. Salgado C.M., Basu D., Nikiforova M., Bauer B.S., Johnson D., Rundell V. et al. BRAFmutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi. Pediatr Dev Pathol. 2015;18(1):1–9. https://doi.org/10.2350/14-10-1566-OA.1
22. Krengel S., Scope A., Dusza S.W., Vonthein R., Marghoob A.A. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol. 2013;68(3):441–451. https://doi.org/10.1016/j.jaad.2012.05.043
23. Евзиков Г.Ю., Башлачев М.Г., Шашкова Е.В., Белозерских К.А., Гребенев Ф.В. Нейрокожный меланоз в сочетании с кистой задней черепной ямки (комплекс Денди–Уокера) и интрадуральной арахноидальной кистой позвоночного канала. Неврология, нейропсихиатрия, психосоматика. 2020;12(2):79–85. [Evzikov G.Yu., Bashlachev M.G., Shashkova E.V., Belozerskikh K.A., Grebenev F.V. Neurocutaneous melanosis concurrent with a posterior cranial fossa cyst (Dandy–Walker complex) and an intradural arachnoid cyst of the spinal canal. Nevrologiya, neiropsikhiatriya, psikhosomatika (Neurology, Neuropsychiatry, Psychosomatic).2020;12(2):79–85. (In Russ.)]. doi: 10.14412/2074-2711-2020-2-79-85
24. Прыгунова Т.М., Карпович Е.И., Чернигина М.Н., Береснева Е.Е., Трынкова Л.А. Особенности течения нейрокожного меланоза у детей. Вопросы современной педиатрии. 2016;15(5):513–521. [Prygunova T.M., Karpovich E.I., Chernigina M.N., Beresneva E.E., Trynkova L.A. Course peculiarities of neurocutaneous melanosis in children. Voprosy sovremennoi pediatrii — Current Pediatrics. 2016;15(5):513–521. (In Russ.)]. https://doi.org/10.15690/vsp.v15i5.1626
25. Корниенко В.Н., Серков С.В., Пронин И.Н., Eriksen M.R., Коршунов А.Г. Нейрокожный меланоз в сочетании с интракраниальной беспигментной меланомой (клиническое наблюдение). Медицинская визуализация. 2003;3:27–33. [Kornienko V.N., Serkov S.V., Pronin I.N., Eriksen M.R., Korshunov A.G. Neurocutaneous Melanosis and Anaplastic Melanoma of the Brain (Case Report). Medical Visualization. 2003;3:27–33. (In Russ.)].
26. Субботин А.В., Семенов В.А., Сидоров А.В., Мошнегуц С.В., Зуева С.А., Колядов В.А Меланоматоз головного мозга — сложная проблема современной медицины. Дальневосточный медицинский журнал. 2021;2:65–69. [Subbotin A.V., Semenov V.A., Sidorov A.V., Moshneguts S.V., Zueva S.A., Kolyadov V.A. Melanomatosis of the brain — a complex problem of modern medicine. Far Eastern Medical Journal. 2021;2:65–69. (In Russ.)]. http://dx.doi.org/10.35177/1994-5191-2021-2-65-69
27. Коновалов А.Н., Пицхелаури Д.И., Быканов А.Е., Грачев Н.С., Никитин П.В. Первичная меланоцитома пинеальной области: клинический случай и обзор литературы. Вопросы нейрохирургии им. Н.Н. Бурденко. 2019;83(5):44–50. [Konovalov A.N., Pitskhelauri D.I., Bykanov A.E., Grachev N.S., Nikitin P.V. Primary pineal melanocytoma: clinical case and literature review. Zhurnal Voprosy Neirokhirurgii Imeni N.N. Burdenko. 2019;83(5):44–50. (In Russ.)]. https://doi.org/10.17116/neiro20198305144
Review
For citations:
Grigoryeva V.N., Nesterova V.N., Tikhomirov G.V., Klimova O.S., Chudakova I.V. Neurocutaneous melanocytosis with manifestation in adulthood. Russian neurological journal. 2022;27(5):59-69. (In Russ.) https://doi.org/10.30629/2658-7947-2022-27-5-59-68